Symbol
ABMD
ISIN
US0036541003
Börse
NASDAQ
Sektor
Health Care
Marktkapitalisierung
14.8987 Mrd. US
Branche
Health Care Equipment & Supplies
Dividendenrendite
0 %
Ausschüttungsquote
0 %
KGV
72.46
KUV (TTM)
18.42
KGVe
0.00
Kursziel
326.6 USD
Symbol
ABMD
ISIN
US0036541003
Börse
NASDAQ
Marktkapitalisierung
14.8987 Mrd. USD
Sektor
Health Care
Branche
Health Care Equipment & Supplies
Dividendenrendite
0 %
Ausschüttungsquote
0 %
KGV
72.46
KUV (TTM)
18.42
KGVe
0.00
Kursziel
326.6 USD
Live-Chart (verzögert)
Firmenbeschreibung
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Abiomed, Inc Fundamentaldaten
Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)
Das Geschäftsjahr von Abiomed, Inc endet im März.
Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.045 | 0.062 | 0.000 | 0.000 | 0.107 |
2020 | 0.089 | 0.013 | 0.069 | 0.032 | 0.203 |
2019 | 0.090 | 0.050 | 0.045 | 0.074 | 0.259 |
2018 | 0.037 | 0.025 | 0.013 | 0.037 | 0.112 |
2017 | 0.013 | 0.009 | 0.015 | 0.015 | 0.052 |
2016 | 0.009 | 0.008 | 0.011 | 0.011 | 0.038 |
2015 | -0.002 | 0.004 | 0.013 | 0.099 | 0.114 |
2014 | -0.002 | 0.001 | 0.004 | 0.004 | 0.007 |
2013 | 0.003 | 0.005 | 0.003 | 0.004 | 0.015 |
2012 | -0.005 | 0.001 | 0.003 | 0.003 | 0.001 |
2011 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
2010 | 0.000 | 0.000 | 0.000 | 0.001 | 0.001 |
Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.58 | 1.01 | 0 | 0 | 1.59 |
2020 | 1 | 1.0261 | 1.11 | 0.98 | 4.1161 |
2019 | 0.78 | 0.81 | 0.93 | 1.07 | 3.59 |
2018 | 0.4511 | 0.44 | 0.7 | 0.8 | 2.3911 |
2017 | 0.29 | 0.2 | 0.34 | 0.4007 | 1.2307 |
2016 | 0.2 | 0.17 | 0.23 | 0.24 | 0.84 |
2015 | -0.04 | 0.09 | 0.3 | 0.28 | 0.63 |
2014 | -0.04 | 0.07 | 0.11 | 0.09 | 0.23 |
2013 | 0.08 | 0.13 | 0.07 | 0.09 | 0.37 |
2012 | -0.12 | 0.02 | 0.05 | 0.06 | 0.01 |
2011 | -0.16 | -0.09 | -0.02 | -0.05 | -0.32 |
2010 | -0.21 | -0.21 | -0.12 | -0.13 | -0.67 |
Umsatz pro Jahr & Quartal in Mrd. USD
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.16485 | 0.209764 | 0 | 0 | 0.374614 |
2020 | 0.207666 | 0.204974 | 0.200563 | 0.16485 | 0.778053 |
2019 | 0.18001 | 0.181778 | 0.207081 | 0.206658 | 0.775527 |
2018 | 0.132468 | 0.132823 | 0.174436 | 0.207081 | 0.646808 |
2017 | 0.102995 | 0.102955 | 0.114674 | 0.174436 | 0.49506 |
2016 | 0.073432 | 0.076359 | 0.085795 | 0.093957 | 0.329543 |
2015 | 0.048811 | 0.051938 | 0.062005 | 0.067557 | 0.230311 |
2014 | 0.04267 | 0.044345 | 0.046195 | 0.050433 | 0.183643 |
2013 | 0.038783 | 0.037417 | 0.03825 | 0.043674 | 0.158124 |
2012 | 0.027355 | 0.029478 | 0.032198 | 0.037344 | 0.126375 |
2011 | 0.022002 | 0.023376 | 0.027244 | 0.028529 | 0.101151 |
2010 | 0.019913 | 0.020022 | 0.022799 | 0.022979 | 0.085713 |
Umsatz je Aktie pro Jahr & Quartal
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 3.58 | 4.56 | 0.00 | 0.00 | 1.69 |
2020 | 4.51 | 4.46 | 4.36 | 3.58 | 16.91 |
2019 | 3.91 | 3.95 | 4.50 | 4.49 | 16.86 |
2018 | 2.88 | 2.89 | 3.79 | 4.50 | 14.06 |
2017 | 2.29 | 2.29 | 2.55 | 3.88 | 11.00 |
2016 | 1.67 | 1.70 | 1.91 | 2.09 | 7.32 |
2015 | 1.22 | 1.24 | 1.44 | 1.57 | 5.36 |
2014 | 1.09 | 1.08 | 1.10 | 1.20 | 4.37 |
2013 | 0.92 | 0.89 | 0.93 | 1.07 | 3.86 |
2012 | 0.72 | 0.76 | 0.80 | 0.93 | 3.16 |
2011 | 0.59 | 0.63 | 0.74 | 0.77 | 2.73 |
2010 | 0.54 | 0.54 | 0.62 | 0.62 | 2.32 |
Gewinn-Wachstum in Prozent
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 40.22 | 39.53 | -100.00 | 0.00 | -47.39 |
2020 | 20.23 | -85.30 | 429.55 | -54.06 | -21.62 |
2019 | 144.43 | -44.34 | -10.50 | 64.86 | 130.91 |
2018 | 150.85 | -34.44 | -45.13 | 174.04 | 115.23 |
2017 | 17.38 | -31.25 | 73.88 | -3.45 | 36.62 |
2016 | -91.04 | -12.69 | 36.46 | 4.20 | -66.45 |
2015 | -147.18 | 0.00 | 230.40 | 679.52 | 1446.57 |
2014 | -146.04 | 0.00 | 314.83 | -17.55 | -51.04 |
2013 | 21.50 | 75.34 | -50.92 | 39.42 | 904.28 |
2012 | 0.00 | 0.00 | 386.02 | -12.12 | 0.00 |
2011 | -100.00 | 0.00 | 0.00 | 0.00 | -100.00 |
2010 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Umsatz-Wachstum in Prozent
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.00 | 27.25 | 0.00 | 0.00 | 0.00 |
2020 | 0.49 | -1.30 | -2.15 | -17.81 | 0.33 |
2019 | -13.07 | 0.98 | 13.92 | -0.20 | 19.90 |
2018 | -24.06 | 0.27 | 31.33 | 18.71 | 30.65 |
2017 | 9.62 | -0.04 | 11.38 | 52.11 | 50.23 |
2016 | 8.70 | 3.99 | 12.36 | 9.51 | 43.09 |
2015 | -3.22 | 6.41 | 19.38 | 8.95 | 25.41 |
2014 | -2.30 | 3.93 | 4.17 | 9.17 | 16.14 |
2013 | 3.85 | -3.52 | 2.23 | 14.18 | 25.12 |
2012 | -4.12 | 7.76 | 9.23 | 15.98 | 24.94 |
2011 | -4.25 | 6.24 | 16.55 | 4.72 | 18.01 |
2010 | 1.69 | 0.55 | 13.87 | 0.79 | 17.08 |
Abiomed, Inc Fundamentaldaten
Gewinn pro Jahr & Quartal (Net Income)
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.045 | 0.062 | 0.000 | 0.000 | 0.107 |
2020 | 0.089 | 0.013 | 0.069 | 0.032 | 0.203 |
2019 | 0.090 | 0.050 | 0.045 | 0.074 | 0.259 |
2018 | 0.037 | 0.025 | 0.013 | 0.037 | 0.112 |
2017 | 0.013 | 0.009 | 0.015 | 0.015 | 0.052 |
2016 | 0.009 | 0.008 | 0.011 | 0.011 | 0.038 |
2015 | -0.002 | 0.004 | 0.013 | 0.099 | 0.114 |
2014 | -0.002 | 0.001 | 0.004 | 0.004 | 0.007 |
2013 | 0.003 | 0.005 | 0.003 | 0.004 | 0.015 |
2012 | -0.005 | 0.001 | 0.003 | 0.003 | 0.001 |
2011 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
2010 | 0.000 | 0.000 | 0.000 | 0.001 | 0.001 |
Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.58 | 1.01 | 0 | 0 | 1.59 |
2020 | 1 | 1.0261 | 1.11 | 0.98 | 4.1161 |
2019 | 0.78 | 0.81 | 0.93 | 1.07 | 3.59 |
2018 | 0.4511 | 0.44 | 0.7 | 0.8 | 2.3911 |
2017 | 0.29 | 0.2 | 0.34 | 0.4007 | 1.2307 |
2016 | 0.2 | 0.17 | 0.23 | 0.24 | 0.84 |
2015 | -0.04 | 0.09 | 0.3 | 0.28 | 0.63 |
2014 | -0.04 | 0.07 | 0.11 | 0.09 | 0.23 |
2013 | 0.08 | 0.13 | 0.07 | 0.09 | 0.37 |
2012 | -0.12 | 0.02 | 0.05 | 0.06 | 0.01 |
2011 | -0.16 | -0.09 | -0.02 | -0.05 | -0.32 |
2010 | -0.21 | -0.21 | -0.12 | -0.13 | -0.67 |
Umsatz pro Jahr & Quartal
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.16485 | 0.209764 | 0 | 0 | 0.374614 |
2020 | 0.207666 | 0.204974 | 0.200563 | 0.16485 | 0.778053 |
2019 | 0.18001 | 0.181778 | 0.207081 | 0.206658 | 0.775527 |
2018 | 0.132468 | 0.132823 | 0.174436 | 0.207081 | 0.646808 |
2017 | 0.102995 | 0.102955 | 0.114674 | 0.174436 | 0.49506 |
2016 | 0.073432 | 0.076359 | 0.085795 | 0.093957 | 0.329543 |
2015 | 0.048811 | 0.051938 | 0.062005 | 0.067557 | 0.230311 |
2014 | 0.04267 | 0.044345 | 0.046195 | 0.050433 | 0.183643 |
2013 | 0.038783 | 0.037417 | 0.03825 | 0.043674 | 0.158124 |
2012 | 0.027355 | 0.029478 | 0.032198 | 0.037344 | 0.126375 |
2011 | 0.022002 | 0.023376 | 0.027244 | 0.028529 | 0.101151 |
2010 | 0.019913 | 0.020022 | 0.022799 | 0.022979 | 0.085713 |
Umsatz je Aktie pro Jahr & Quartal
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 3.58 | 4.56 | 0.00 | 0.00 | 1.69 |
2020 | 4.51 | 4.46 | 4.36 | 3.58 | 16.91 |
2019 | 3.91 | 3.95 | 4.50 | 4.49 | 16.86 |
2018 | 2.88 | 2.89 | 3.79 | 4.50 | 14.06 |
2017 | 2.29 | 2.29 | 2.55 | 3.88 | 11.00 |
2016 | 1.67 | 1.70 | 1.91 | 2.09 | 7.32 |
2015 | 1.22 | 1.24 | 1.44 | 1.57 | 5.36 |
2014 | 1.09 | 1.08 | 1.10 | 1.20 | 4.37 |
2013 | 0.92 | 0.89 | 0.93 | 1.07 | 3.86 |
2012 | 0.72 | 0.76 | 0.80 | 0.93 | 3.16 |
2011 | 0.59 | 0.63 | 0.74 | 0.77 | 2.73 |
2010 | 0.54 | 0.54 | 0.62 | 0.62 | 2.32 |
Gewinn-Wachstum in Prozent
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 40.22 | 39.53 | -100.00 | 0.00 | -47.39 |
2020 | 20.23 | -85.30 | 429.55 | -54.06 | -21.62 |
2019 | 144.43 | -44.34 | -10.50 | 64.86 | 130.91 |
2018 | 150.85 | -34.44 | -45.13 | 174.04 | 115.23 |
2017 | 17.38 | -31.25 | 73.88 | -3.45 | 36.62 |
2016 | -91.04 | -12.69 | 36.46 | 4.20 | -66.45 |
2015 | -147.18 | 0.00 | 230.40 | 679.52 | 1446.57 |
2014 | -146.04 | 0.00 | 314.83 | -17.55 | -51.04 |
2013 | 21.50 | 75.34 | -50.92 | 39.42 | 904.28 |
2012 | 0.00 | 0.00 | 386.02 | -12.12 | 0.00 |
2011 | -100.00 | 0.00 | 0.00 | 0.00 | -100.00 |
2010 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Umsatz-Wachstum in Prozent
Q1 Apr-Jun |
Q2 Jul-Sep |
Q3 Okt-Dez |
Q4 Jan-Mrz |
Jahr Apr-Mrz |
|
---|---|---|---|---|---|
2021 | 0.00 | 27.25 | 0.00 | 0.00 | 0.00 |
2020 | 0.49 | -1.30 | -2.15 | -17.81 | 0.33 |
2019 | -13.07 | 0.98 | 13.92 | -0.20 | 19.90 |
2018 | -24.06 | 0.27 | 31.33 | 18.71 | 30.65 |
2017 | 9.62 | -0.04 | 11.38 | 52.11 | 50.23 |
2016 | 8.70 | 3.99 | 12.36 | 9.51 | 43.09 |
2015 | -3.22 | 6.41 | 19.38 | 8.95 | 25.41 |
2014 | -2.30 | 3.93 | 4.17 | 9.17 | 16.14 |
2013 | 3.85 | -3.52 | 2.23 | 14.18 | 25.12 |
2012 | -4.12 | 7.76 | 9.23 | 15.98 | 24.94 |
2011 | -4.25 | 6.24 | 16.55 | 4.72 | 18.01 |
2010 | 1.69 | 0.55 | 13.87 | 0.79 | 17.08 |
Abiomed, Inc Dividenden-Entwicklung
Ex-Tag | Record Date | Zahltag | Dividende |
---|---|---|---|
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
0000-00-00 | 0000-00-00 | 0000-00-00 | 0 |
Hinterlasse einen Kommentar